Clinical pathways have been shown to be effective in improving quality of care for patients admitted to hospital for acute coronary syndromes (ACS) in high-income countries. However, their utility has not formally been evaluated in low- or middle-income countries. The Clinical Pathways for Acute Coronary Syndromes in China program is a 7-year study with the overall goal of reducing evidence-practice gaps in the management of patients admitted to hospitals in China with suspected ACS. The program comprises 2 phases: a prospective survey of current management of ACS patients to identify the areas that evidence-based patient care can be potentially improved, and a quality care initiative to maximize the use of evidence-based investigations and treatments for ACS patients in China. In this article, we outline the details of the study protocol, including key aspects of the development, implementation, and evaluation of the quality improvement initiative (clinical pathway) for management of patients with suspected ACS.
AD - George Institute for Global Health, The University of Sydney, Missenden Road, Sydney, Australia. AN - 20802266 BT - Critical Pathways in Cardiology ET - 2010/08/31 LA - eng M1 - 3 N1 - Rong, YeTurnbull, FionaPatel, AnushkaDu, XinWu, YangfengGao, RunlinCPACS investigatorsResearch Support, Non-U.S. Gov'tUnited StatesCritical pathways in cardiologyCrit Pathw Cardiol. 2010 Sep;9(3):134-9. N2 -Clinical pathways have been shown to be effective in improving quality of care for patients admitted to hospital for acute coronary syndromes (ACS) in high-income countries. However, their utility has not formally been evaluated in low- or middle-income countries. The Clinical Pathways for Acute Coronary Syndromes in China program is a 7-year study with the overall goal of reducing evidence-practice gaps in the management of patients admitted to hospitals in China with suspected ACS. The program comprises 2 phases: a prospective survey of current management of ACS patients to identify the areas that evidence-based patient care can be potentially improved, and a quality care initiative to maximize the use of evidence-based investigations and treatments for ACS patients in China. In this article, we outline the details of the study protocol, including key aspects of the development, implementation, and evaluation of the quality improvement initiative (clinical pathway) for management of patients with suspected ACS.
PY - 2010 SN - 1535-2811 (Electronic)1535-2811 (Linking) SP - 134 EP - 9 T2 - Critical Pathways in Cardiology TI - Clinical pathways for acute coronary syndromes in China: protocol for a hospital quality improvement initiative VL - 9 ER -